Lupus Nephritis Clinical Trials in Los Angeles, California

4 studies are recruiting for lupus nephritis in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. VIBRANT: VIB4920 for Active Lupus Nephritis

    This is a multi-center double-blind placebo controlled clinical trial evaluating the efficacy of VIB4920 combined with mycophenolate mofetil (MMF) and prednisone in achieving a renal response in participants with active lupus nephritis (LN).

    Stage
    Phase 2
    Ages
    18 and older
    Site
    UCLA Medical Center: Division of Rheumatology, Los Angeles, California
    Locations
    17 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT05201469 on ClinicalTrials.gov

  2. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

    The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    Ronald Reagan UCLA Medical Center, Los Angeles, California
    Locations
    103 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT05268289 on ClinicalTrials.gov

  3. A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

    This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants with moderate-to-severe active systemic lupus erythematosus (SLE) with or without nephritis, antine…

    Stage
    Phase 1
    Ages
    12 to 70
    Site
    Children's Hospital Los Angeles Division Of Rheumatology, Los Angeles, California
    Locations
    21 in total
    Run by
    Fate Therapeutics

    See if you can join NCT06308978 on ClinicalTrials.gov

  4. Lupus Landmark Study: A Prospective Registry and Biorepository

    The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

    Stage
    Not phased
    Ages
    18 to 110
    Site
    UCLA, Los Angeles, California
    Locations
    25 in total
    Run by
    Lupus Research Alliance

    See if you can join NCT05934149 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.